709
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Is COPD a Risk Factor for Hip Fracture?

, , , , , & show all

References

  • Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Updated 2016. Available at: http://www.goldcopd.org/uploads/users/files/GOLD_Report%202016.pdf Accessed on: January 7, 2016.
  • Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Spanish guideline for COPD (GesEPOC). Update 2014. Arch Bronconeumol 2014; 50(Suppl 1):1–16.
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379(9823):1341–1351.
  • Teng GG, Curtis JR, Saag KG. Quality health care gaps in osteoporosis: how can patients, providers, and the health system do a better job? Curr Osteoporos Rep 2009; 7(1):27–34.
  • Jørgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007; 101(1):177–185.
  • Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009; 136(6):1456–1465.
  • Silva DR, Coelho AC, Dumke A, Valentini JD, de Nunes JN, Stefani CL, et al. Osteoporosis prevalence and associated factors in patients with COPD: a cross-sectional study. Respir Care 2011; 56(7):961–968.
  • Graat-Verboom L, Smeenk FW, van den Borne BE, Spruit MA, Donkers-van Rossum AB, Aarts RP, et al. Risk factors for osteoporosis in Caucasian patients with moderate chronic obstructive pulmonary disease: a case control study. Bone 2012; 50(6):1234–1239.
  • Graat-Verboom L, Smeenk FW, van den Borne BE, Spruit MA, Jansen FH, van Enschot JW, et al. Progression of osteoporosis in patients with COPD: a 3-year follow up study. Respir Med 2012; 106(6):861–870.
  • Watanabe R, Tanaka T, Aita K, Hagiya M, Homma T, Yokosuka K, et al. Osteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary function. J Bone Miner Metab 2015; 33(4):392–400.
  • Lin CW, Chen YY, Chen YJ, Liang CY, Lin MS, Chen W. Prevalence, risk factors, and health-related quality of life of osteoporosis in patients with COPD at a community hospital in Taiwan. Int J Chron Obstruct Pulmon Dis 2015; 10:1493–1500.
  • Chen SJ, Liao WC, Huang KH, Lin CL, Tsai WC, Kung PT, et al. Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study. QJM 2015; 108(8):633–640.
  • Romme EA, Geusens P, Lems WF, Rutten EP, Smeenk FW, van den Bergh JP, et al. Fracture prevention in COPD patients; a clinical 5-step approach. Respir Res 2015; 16:32.
  • Kim GW, Joo HJ, Park TS, Lee JS, Lee SW, Jung YJ, et al. Vertebral compression fractures may increase mortality in male patients with chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 2015; 19(5):603–609.
  • Regan EA, Radcliff TA, Henderson WG, Cowper Ripley DC, Maciejewski ML, Vogel WB, et al. Improving hip fractures outcomes for COPD patients. COPD 2013; 10(1):11–19.
  • Miller BJ, Lu X, Cram P. The trends in treatment of femoral neck fractures in the Medicare population from 1991 to 2008. J Bone Joint Surg Am 2013; 95(18):e132.
  • de Luise C, Brimacombe M, Pedersen L, Sørensen HT. Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study. Eur J Epidemiol 2008; 23(2):115–122.
  • Azagra R, López-Expósito F, Martin-Sánchez JC, Aguyé A, Moreno N, Cooper C, et al. Changing trends in the epidemiology of hip fracture in Spain. Osteoporos Int 2014; 25(4):1267–1274.
  • Instituto Nacional de Gestión Sanitaria, Ministerio de Sanidad, Servicios Sociales e Igualdad: Conjunto Mínimo Básico de Datos, Hospitales del INSALUD. Available at: http://www.ingesa.msc.es/estadEstudios/documPublica/CMBD-2001.htm. Accessed on: January 7, 2016.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373–383.
  • Thomsen RW, Nielsen JS, Ulrichsen SP, Pedersen L, Hansen AM, Nilsson T. The Danish Centre for Strategic Research in Type 2 Diabetes (DD2) study: collection of baseline data from the first 580 patients. Clin Epidemiol 2012; 4:43–48.
  • Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Tauleria E, Sanchez G, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64(10):863–868.
  • Ministerio de Sanidad, Servicios Sociales e Igualdad: Encuesta Nacional de Salud de España. Available at: http://www.msssi.gob.es/estadEstudios/estadisticas/encuestaNacional/. Accessed on: January 7, 2016.
  • Instituto Nacional de Estadística: Population estimates 2010. Available at: http://www.ine.es. Accessed on: January 7, 2016.
  • Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19:335–351.
  • Joinpoint Regression Program. Statistical methodology and applications branch, surveillance research program, National Cancer Institute. Version 4.0.4. 2013.
  • Paksima N, Koval KJ, Aharanoff G, Walsh M, Kubiak EN, Zuckerman JD, et al. Predictors of mortality after hip fracture: a 10-year prospective study. Bull NYU Hosp Jt Dis 2008; 66(2):111–117.
  • Jimenez-Garcıa R, Villanueva-Martınez M, Fernandez-de-Las-Penas C, Hernandez-Barrera V, Rıos-Luna A, Garrido PC, et al. Trends in primary total hip arthroplasty in Spain from 2001 to 2008: evaluating changes in demographics, comorbidity, incidence rates, length of stay, costs and mortality. BMC Musculoskelet Disord 2011;12:43.
  • Chevalley T, Guilley E, Herrmann FR, Hoffmeyer P, Rapin CH, Rizzoli R. Incidence of hip fracture over a 10-year period (1991–2000): reversal of a secular trend. Bone 2007; 40:1284–1289.
  • Langhammer A, Forsmo S, Syversen U. Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis 2009; 4:365–380.
  • Cielen N, Maes K, Gayan-Ramirez G. Musculoskeletal disorders in chronic obstructive pulmonary disease. Biomed Res Int 2014; 2014:965764.
  • Vestergaard P, Rejnmark L, Mosekilde L. Fracture risk associated with systemic and topical corticosteroids. J Intern Med 2005; 257(4):374–384.
  • Díez-Manglano J, López-García F, Barquero-Romero J, Galofré-Alvaro N, Montero-Rivas L, Almagro-Mena P, et al. Risk of osteoporotic fracture and hip fracture in patients with chronic obstructive pulmonary disease. Rev Clin Esp 2011; 211(9):443–449.
  • Reyes C, Estrada P, Nogués X, Orozco P, Cooper C, Díez-Pérez A, et al. The impact of common co-morbidities (as measured using theCharlson index) on hip fracture risk in elderly men: a population-based cohort study. Osteoporos Int 2014; 25(6):1751–1758.
  • Radcliff TA, Henderson WG, Stoner TJ, Khuri SF, Dohm M, Hutt E. Patient risk factors, operative care, and outcomes among older community-dwelling male veterans with hip fracture. J Bone Joint Surg Am 2008; 90(1):34–42.
  • Sandby-Thomas M, Sullivan G, Hall JE. A national survey into the peri-operative anaesthetic management of patients presenting for surgical correction of a fractured neck of femur. Anaesthesia 2008; 63(3):250–258.
  • Vidán MT, Sánchez E, Gracia Y, Marañón E, Vaquero J, Serra JA. Causes and effects of surgical delay in patients with hip fracture: a cohort study. Ann Intern Med 2011; 155(4):226–233.
  • Lawrence VA, Cornell JE, Smetana GW. Strategies to reduce postoperative pulmonary complications after noncardiothoracic surgery: systematic review for the American College of Physicians. Ann Intern Med 2006; 144(8):596–608.
  • Smetana GW. Preoperative pulmonary evaluation: identifying and reducing risks for pulmonary complications. Cleve Clin J Med 2006; 73(Suppl. 1):S36–S41.
  • Dell RM, Greene D, Anderson D, Williams K. Osteoporosis disease management: what every orthopaedic surgeon should know. J Bone Joint Surg Am 2009; 91(Suppl. 6):79–86.
  • Requena G, Abbing-Karahagopian V, Huerta C, De Bruin ML, Alvarez Y, Miret M, et al. Incidence rates and trends of hip/femur fractures in five European countries: comparison using e-healthcare records databases. Calcif Tissue Int 2014; 94(6):580–589.
  • Wu TY, Jen MH, Bottle A, Liaw CK, Aylin P, Majeed A. Admission rates and in-hospital mortality for hip fractures in England 1998 to 2009: time trends study. J Public Health 2011; 33:284–291.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.